Welltower (WELL, $75.02) Buys a 23-Property Medical Portfolio for $400M
Welltower Inc., a Healthcare Real Estate Investment Trust (REIT), recently acquired a 23-property medical office portfolio from the Milwaukee-based private equity firm, Hammes Partners, for $400 million.
Spanning across a whopping 979,000 square feet, the portfolio is spread across 12 metro markets in Virginia, Washington, North Carolina, Illinois, New York, New Jersey, Pennsylvania, Alabama, and Texas and consists of outpatient properties affiliated with healthcare systems and other providers.
Consisting of ~3.3 million rentable square feet in major metropolitan markets across 16 states, the sale is expected to close by the first half of 2019. However, it is subject to customary closing conditions.
Jones Lang Lasalle Inc. (JLL), global real estate services firm specializing in commercial property and investment management, handled the sale for Hammes Partners.
WELL in upward trend: price rose above 50-day moving average on April 22, 2024
WELL moved above its 50-day moving average on April 22, 2024 date and that indicates a change from a downward trend to an upward trend. In of 48 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on April 23, 2024. You may want to consider a long position or call options on WELL as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for WELL just turned positive on April 22, 2024. Looking at past instances where WELL's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WELL advanced for three days, in of 329 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 10-day moving average for WELL crossed bearishly below the 50-day moving average on April 12, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WELL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for WELL entered a downward trend on April 23, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. WELL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.060) is normal, around the industry mean (1.954). P/E Ratio (133.319) is within average values for comparable stocks, (61.563). Projected Growth (PEG Ratio) (2.183) is also within normal values, averaging (6.879). Dividend Yield (0.026) settles around the average of (0.069) among similar stocks. P/S Ratio (7.189) is also within normal values, averaging (7.128).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a real estate investment trust
Industry RealEstateInvestmentTrusts